-+ 0.00%
-+ 0.00%
-+ 0.00%

GILEAD: PLANS TO INITIATE PHASE 3 EMVISTEGRAST MONOTHERAPY STUDY IN 2027

Reuters·10/19/2026 10:01:05

Please log in to view news